Why GLP-1 drugs might reduce cancer risk

Keyword: Risk Factor

Publisher: Scientific American

Published: Jun 8, 2026

CHICAGO—At the world’s largest oncology conference, Ozempic, a diabetes drug, found its way to the center of the conversation. As thousands of attendees bounced between presentations at the American … [+7360 chars]

Read Full Story ↗

Related Content

Related Story Testosterone is being overprescribed to men — here's who should take it, and when it backfires

Business Insider
Related Story A 49-year-old triathlete suddenly lost vision in one eye. He was diagnosed with stage 4 lung cancer, despite never smoking.

Business Insider
Related Story Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

Science Daily